EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PCSK9 inhibition alleviates sepsis-induced myocardial dysfunction by facilitating PINK1/parkin-associated mitophagy

Jiancheng Lin, Zetao Pan, Jiayan Sun, Xiaowan Wang, Linna Zhang, Yuheng Ye, Di Yin, Yi Wang, Qiang Guo

Frontiers in Pharmacology · 03.07.2026 · 17

DOI: 10.3389/fphar.2026.1844269 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.07.2026. Verfasst von Jiancheng Lin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Soochow University, Suzhou, Jiangsu, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sepsis-induced myocardial dysfunction (SIMD), also known as septic cardiomyopathy in sepsis patients is associated with worse prognosis and higher mortality compared to sepsis cases without SIMD. Early intervention and comprehensive management are crucial for improving survival, particularly in the early stages of sepsis. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a promising therapeutic target in the cardiovascular system. While PCSK9 has been implicated in cardiovascular inflammation and injury, specific evidence regarding the potential of PCSK9 inhibition to mitigate SIMD remains limited.

Methods

An in vivo mouse model of sepsis was established using cecal ligation and puncture (CLP), and SIMD was assessed through echocardiography and right ventricular systolic pressure measurements. For in vitro cellular SIMD models, lipopolysaccharide was administered to HL-1 and H9c2 cardiomyocytes. Data concerning apoptosis, inflammatory responses, oxidative stress, and mitophagy were evaluated across both models.

Results

The SIMD models were successfully established both in vivo and in vitro . PCSK9 inhibition visibly attenuated myocardial dysfunction, cellular injury, apoptosis, inflammation, and oxidative stress, which was accompanied by enhanced mitophagic clearance. Furthermore, the application of Mdivi-1, a mitochondrial division inhibitor that impairs mitophagy, revealed that the cardioprotective effects of PCSK9 inhibition are at least partially dependent on the preservation of mitophagy. Mechanistically, PCSK9 inhibition appeared to facilitate mitophagic flux in SIMD, potentially via the PINK1/Parkin signaling pathway.

Conclusion

These findings suggest that the protective effects of PCSK9 inhibition against SIMD are closely associated with the enhancement of mitophagy and the modulation of the PINK1/Parkin pathway. Furthermore, this intervention correlates with attenuated oxidative stress, inflammation, and apoptosis, ultimately offering a potential therapeutic strategy for myocardial injury.

Schlagwörter

Stichwörter der Autor:innen

PCSK9evolocumabmitochondrial dynamicsmitochondrial quality controlmitophagysepsis-induced myocardial dysfunction

Autor:innen und Institutionen

  • Medical College of Soochow University, Suzhou, Jiangsu, China.
  • Medical Center of Soochow University, Suzhou, Jiangsu, China.
  • Department of Emergency and Critical Care Medicine, The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, Jiangsu, China.
  • Department of Critical Care Medicine, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.

Zitieren

APA

Lin, J., Pan, Z., Sun, J., Wang, X., Zhang, L., Ye, Y., Yin, D., Wang, Y., & Guo, Q. (2026). PCSK9 inhibition alleviates sepsis-induced myocardial dysfunction by facilitating PINK1/parkin-associated mitophagy. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1844269

Vancouver

Lin J, Pan Z, Sun J, Wang X, Zhang L, Ye Y, et al. PCSK9 inhibition alleviates sepsis-induced myocardial dysfunction by facilitating PINK1/parkin-associated mitophagy. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1844269

BibTeX
@article{Lin2026,
  author = {Lin, Jiancheng and Pan, Zetao and Sun, Jiayan and Wang, Xiaowan and Zhang, Linna and Ye, Yuheng and Yin, Di and Wang, Yi and Guo, Qiang},
  title = {PCSK9 inhibition alleviates sepsis-induced myocardial dysfunction by facilitating PINK1/parkin-associated mitophagy},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1844269}
}
Kostenlos starten →